Dr. Michael Isaac Ellenbogen, MD

Dr. Ellenbogen practices at Johns Hopkins University, PM and R in Baltimore, Maryland.

Dr. Ellenbogen's NPI, 1336433697, was assigned on June 4, 2011. Dr. Ellenbogen holds Illinois license 125059268.

Dr. Ellenbogen's primary practice is Johns Hopkins University, PM and R, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Ellenbogen's primary practice is Johns Hopkins University, PM and R in Baltimore, Maryland.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ellenbogen practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Ellenbogen's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ellenbogen is licensed in Illinois.

CMS data shows 139 Medicare services from Dr. Ellenbogen across 3 procedure codes in 2024, for 47 Medicare patients. Medicare paid $10,548 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Ellenbogen in 2024. The largest group is under 65, with 14 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

In 2024, Dr. Ellenbogen wrote 20 Medicare Part D claims. 90% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Ellenbogen for performance year 2024, reported as part of a group.

Dmand AI links 27 papers to Dr. Ellenbogen, published from 2015 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Hospitals, Medicare and Medicaid. Dr. Ellenbogen has published most often in J Hosp Med. Dr. Ellenbogen's most frequent co-authors are Daniel J. Brotman, MD, Jodi Beth Segal, MD and Steven B. Deitelzweig, MD.

CMS Open Payments shows 2 general payments to Dr. Ellenbogen from 2 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $128.